Biography

Dr. Schorge was born and raised in mid-Michigan. He enrolled in the Honors Program at the University of Michigan, where he became a life-long Wolverines fan and met his future wife. He had a brief immersion in Southern culture during medical school at Vanderbilt University. Dr. Schorge next served an OB/GYN resident at the integrated Brigham & Women's Hospital-Mass General program before completing a gynecologic oncology fellowship at 'the Brigham'. He was on the faculty at the University of Texas Southwestern Medical School-Parkland Memorial Hospital in Dallas for eight years before returning to Boston as Chief of GYN Oncology at Mass General. Dr. Schorge has been married for 20+ years and has three children. He is a member of Red Sox Nation and the entire family proudly wear Tom Brady jerseys [U-Michigan alumnus].

Research & Publications

Dr. Schorge's research interests primarily focus on ovarian cancer. He was the lead author on the 2010 Society of Gynecologic Oncology White Paper describing the etiology, screening and surveillance of this disease. He has spearheaded the investigation of the clinical benefits of cytoreductive surgery and incorporation of ultra-radical techniques to achieve prolonged survival for patients with advanced disease at Mass General - where the concept of aggressive debulking was initially described in the 1930s. He is co-Director of the the GYN ONC tissue repository where patient samples are tested for efficacy of novel treatments [under the supervision of Drs. Bo Rueda, Rosemary Foster and Whit Growdon]. Dr. Schorge is also a committee member of the Gynecologic Oncology Group and serves as the Principal Investigator at Mass General for a therapeutic GOG trial in patients with advanced ovarian cancer. His clinical experience and dedication to education is exemplified by his serving as the lead editor of Williams' Gynecology, a 1500+ page text with surgical atlas.

News & Events

One of the most serious health sequelae of obesity in women is the development of endometrial intraepithelial neoplasia (EIN) and later endometrial adenocarcinoma, attributed in part to the excess production of estrogen. In fact, the rising obesity rate accounts for a nearly 30% increase in the incidence and mortality rate of endometrial cancer over the past five years, in contrast to a general downtrend for other common malignancies.

Multimedia

The multidisciplinary Minimally Invasive Gynecologic Surgery (MIGS) Center includes specialized surgeons, fellows and a variety of other specialists. Our surgeons take a collaborative approach to patient care to determine the best procedure for each patient. Meet members of the MIGS team and hear one patient's story in this video by the American Congress of Obstetricians and Gynecologists (ACOG).